James Darrah

James Darrah serves as Director of Quality & Operational Services, overseeing the strategic procurement and lifecycle management of specialized medical equipment and ophthalmic goods. In this leadership capacity, he ensures compliance with federal acquisition regulations while aligning procurement activities with operational excellence and clinical safety standards. His portfolio centers on the acquisition of precision ophthalmic devices, diagnostic instrumentation, and related manufacturing inputs, supporting critical healthcare delivery systems. Darrah’s role is pivotal in translating clinical needs into technically sound solicitations, ensuring that acquisitions meet rigorous quality control benchmarks and regulatory requirements. While specific contractor relationships are not publicly enumerated, Darrah’s procurement patterns indicate consistent engagement with manufacturers and suppliers certified in medical device production, particularly those adhering to FDA quality systems and ISO 13485 standards. His working relationships emphasize technical capability, supply chain reliability, and adherence to regulatory compliance over price alone, fostering long-term vendor partnerships grounded in performance metrics and quality assurance protocols. Darrah’s contracting activity reflects a strong preference for open competition, with 100% of awards issued under non-set-aside authorities. This indicates a focus on technical merit and operational readiness rather than socioeconomic preferences, suggesting a procurement strategy prioritizing product performance, regulatory compliance, and supply chain resilience over socioeconomic targeting. His primary procurement focus is exclusively within NAICS 339115 — Ophthalmic Goods Manufacturing — encompassing the acquisition of eyeglass frames, contact lenses, surgical instruments, diagnostic optics, and other vision correction and diagnostic devices. Darrah possesses deep expertise in the technical specifications, material standards, and regulatory frameworks governing ophthalmic product manufacturing, ensuring that all acquisitions meet clinical efficacy and safety benchmarks for use in medical and vision care environments.